Enabling speed to clinic for monoclonal antibody programs using a pool of clones for IND-enabling toxicity studies

por Bolisetty, Parimala, Tremml, Gabi, Xu, Sen, Khetan, Anurag
Publicado 2020

Upstream cell culture process characterization and in-process control strategy development at pandemic speed

por Xu, Jianlin, Ou, Jianfa, McHugh, Kyle P., Borys, Michael C., Khetan, Anurag
Publicado 2022

BI-HEX(®)-GlymaxX(® )cells enable efficient production of next generation biomolecules with enhanced ADCC activity

por Puklowski, Anja, Wenger, Till, Schatz, Simone, Koenitzer, Jennifer, Schaub, Jochen, Enenkel, Barbara, Khetan, Anurag, Kaufmann, Hitto, Tolstrup, Anne B
Publicado 2013

N-1 Perfusion Platform Development Using a Capacitance Probe for Biomanufacturing

por Rittershaus, Emily S. C., Rehmann, Matthew S., Xu, Jianlin, He, Qin, Hill, Charles, Swanberg, Jeffrey, Borys, Michael C., Li, Zheng-Jian, Khetan, Anurag
Publicado 2022

Metabolomic and quality data for early and late passages of an antibody-producing industrial CHO cell line

por Sowa, Steven W., Qian, Yueming, Aron, Kathryn L., Xu, Ping, Langsdorf, Erik, Warrack, Bethanne, Aranibar, Nelly, Tremml, Gabi, Xu, Jianlin, McVey, Duncan, Reily, Michael, Khetan, Anurag, Borys, Michael C., Li, Zheng Jian
Publicado 2020

Improved Titer in Late-Stage Mammalian Cell Culture Manufacturing by Re-Cloning

por He, Qin, Rehmann, Matthew S., Tian, Jun, Xu, Jianlin, Sabino, Luzmary, Vandermark, Erik, Basson, Ziev, Po, Iris, Bierilo, Kathleen, Tremml, Gabi, Rizzi, Giovanni, Langsdorf, Erik F., Qian, Nan-Xin, Borys, Michael C., Khetan, Anurag, Li, Zheng-Jian
Publicado 2022